Holocene Advisors’s Twist Bioscience TWST Stock Holding History

Holocene Advisors’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-344,758	Closed	-$16.4M	–	1007
2026 Q1	$16.4M	Buy	+344,758	New	+$15.5M	0.04%	283
2025 Q3	–	Sell	-34,597	Closed	-$1.27M	–	916
2025 Q2	$1.27M	Sell	34,597 -31,571	-48%	-$1.09M	﹤0.01%	623
2025 Q1	$2.6M	Buy	+66,168	New	+$2.98M	0.01%	490

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Holocene Advisors's TWST Position: Q2 2026 in Review

Holocene Advisors sold out of Twist Bioscience (TWST) in Q2 2026, closing a stake of 344,758 shares — an estimated $16.4M sold.

Holocene Advisors first reported a position in TWST in Q1 2025 and held it in 3 quarters. The position peaked at $16.4M in Q1 2026. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Holocene Advisors reported no remaining Twist Bioscience position as of Q2 2026 after selling out during the quarter.
Holocene Advisors sold 344,758 Twist Bioscience shares in Q2 2026, an estimated $16.4M.
Holocene Advisors first reported a position in Twist Bioscience in Q1 2025 and held it in 3 quarters.
Holocene Advisors's Twist Bioscience position peaked at $16.4M in Q1 2026.
335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Holocene Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.